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Abstract 
 
 
In the United States, chronic illness and anxiety disorders are two of the largest burdens 
on the healthcare system. Almost half the population of the United States has been diagnosed 
with a chronic illness, and anxiety disorders are the most commonly diagnosed mental illness. 
The comorbidity between chronic illness and anxiety is fairly common and well-studied. 
Previous research has shown connections between anxiety and hypertension, heart disease, high 
cholesterol, and arthritis. One factor that may maintain the comorbidity between anxiety and 
chronic illness is anxiety sensitivity (AS) and its three subfactors: physical, social, and cognitive. 
The goal of this study was to investigate the relationship between the subfactors of AS and four 
chronic illnesses. In addition, the study looked at the role of anxiety sensitivity in those with 
multiple chronic illnesses and decreased quality of life. Data were gathered from a community 
sample of 1,002 community individuals. Significant relationships were found between 
hypertension and physical AS, and high cholesterol and cognitive AS. All subfactors of AS were 
related to having multiple chronic illnesses, and chronic illness was indicative of decreased 
quality of life.  
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Investigating the Relationship Between Anxiety Sensitivity and Chronic Illness: 
A Replication and Extension 
Introduction 
Chronic illnesses (or noncommunicable diseases, NCDs) are those that cannot be passed 
from person to person, but instead slowly progress throughout the lifetime of a single individual. 
Worldwide, NCDs were responsible for 68% of the world’s 56 million deaths in 2012, with more 
than 40% of the deaths being considered premature (World Health Organization, 2014). In the 
United States alone, more than 117 million adults, almost half of the population, have been 
diagnosed with at least one NCD, with one in four adults having two or more NCDs (Ward, 
2014). Chronic illnesses account for most of the annual healthcare costs in the U.S., consuming 
86% of the country’s annual healthcare budget, totaling over 2.3 trillion dollars (Gerteis, 2014). 
The overall burden of NCDs can be measured using Disability Adjusted Life Years 
(DALY). This measure combines years of life lost (YLL) and years lost to disability (YLD). 
Together DALYs are a measure of how many years of life are lost due to death, illness, or 
impairment (Murray et al., 2012). In 2015, almost 80,000 years were lost per 100,000 people in 
the United States due to NCDs. Fifteen percent of the years lost can be attributed to mental 
diseases, while the other 85 percent are from chronic physical illness (World Health 
Organization Department of Information, Evidence and Research, 2016). Research has shown 
that there is a common comorbidity between mental disorder and chronic physical illness (Tsang 
et al., 2008). Comorbidities can exacerbate the disease condition. Verbrugge, Lepkowski and 
Imanaka (1989) found that as the numbers of comorbidities increase, disability rises 
exponentially. 
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 Anxiety disorders are the most common mental illness in the United States (Facts & 
Statistics, 2017), and comorbidity between chronic illness and anxiety disorders are fairly 
common. Katon, Lin, and Kroenke (2006) reviewed 31 studies regarding the association between 
chronic illnesses and anxiety/depression, finding that any person with a diagnosed chronic illness 
and comorbid anxiety disorder generally perceive more symptoms of the disease than those 
without anxiety. Chronically ill populations also appear to exhibit heightened awareness to 
physical symptoms. The burden of comorbid anxiety disorders and chronic illnesses is more 
likely to increase anxiety symptoms and worsen episodes on top of the taxing symptoms of the 
disease (Katon et al., 2006) 
 The American Heart Association (2013) reports that, in the United States, one out of 
every three persons is hypertensive. Hypertension causes stress to the arteries in the body and a 
comorbidity with anxiety may increase that stress leading to a higher rate of mortality. In a 
review conducted by Pan et al. (2015), the researchers found a significant relationship between 
anxiety and hypertension in cross-sectional studies. In addition, there was a direct association 
seen in prospective studies that were included in the review. They also concluded that those with 
anxiety were at an increased risk for hypertension although there are other variables that come 
into play. In a study conducted with middle aged men, a similar result was seen. Generalized 
Anxiety Disorder was found to be positively associated with hypertension (Carroll, Phillips, 
Gale, & Batty, 2009). Their data suggested that the comorbidity of GAD and hypertension was 
not synergistic, but was acting additively, resulting in an increased disease burden (Carroll et al., 
2009). 
 In the United States alone, over 28 million adults have been diagnosed with heart disease. 
In addition, it is the number one cause of death among Americans (National Center for Health 
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Statistics, 2017). The morbidity and mortality of cardiovascular disease makes understanding of 
associated factors and risks a priority. Vogelzangs et al. (2010) researched the association 
between the presence of an anxiety or depressive disorder and cardiovascular disease. They 
found that anxiety and cardiovascular disease are associated. Their study also examined the 
relationship with coronary heart disease, which is the most common form of cardiovascular 
disease (Heart Disease, 2017). The study found that the prevalence of coronary heart disease 
increased over a variety of anxiety diseases. Those who had an anxiety disorder in the past year 
were up to three times as likely to suffer from coronary heart disease. They further examined the 
amount of time that persons had been diagnosed with anxiety disorders and found that there was 
no significant evidence relating length of diagnosis with increased cardiovascular disease 
(Vogelzangs et al., 2010). 
 High cholesterol is a strong risk factor for the development of cardiovascular disease. 
With the relationship of anxiety disorders and cardiovascular disease, it is important to 
understand if there is a relationship with risk factors as well. Over one third of the adult 
American population has high cholesterol with less than half of those receiving treatment 
(Division for Heart Disease, 2015). Rafter (2001) completed a study with the intention of finding 
biochemical markers for anxiety and depression and found that high total cholesterol is related to 
anxiety. In another study, Peter et al. (2002) found that cholesterol levels were significantly 
higher in subjects with an anxiety disorder or OCD than normal control subjects. A more detailed 
comparison of the population with anxiety disorders showed a significant increase in LDL, and a 
significant decrease in HDL. Of the patients with anxiety disorders, 68% of them had borderline 
or high cholesterol compared to 30% of control subjects. This data led to the assumption that 
elevated cholesterol levels are generally associated to anxiety disorders (Peter et al., 2002). 
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 Arthritis is the leading cause of disability in America, affecting more than 50 million 
adults, with 30 million of those having osteoarthritis (Arthritis Foundation, 2017). Research 
suggests that chronic pain and anxiety disorders are highly comorbid. A study investigating the 
link between anxiety and three chronic pain conditions found that there was a significant 
association that lasted through adjustments for different confounding variables (McWilliams, 
Goodwin, Cox, 2004). Similarly, VanDyke et al. (2004) found that trait anxiety was significantly 
higher in individuals with rheumatoid arthritis than those with osteoarthritis. In addition, as seen 
in the research on cardiovascular disease, disease duration was not found to be statistically 
significant in level of anxiety (VanDyke et al., 2004). This indicates that the presence of anxiety 
was simply related to the presence of disease and was not impacted by the length of time the 
individual had been diagnosed.  
Hypervigilance is one factor that could increase anxiety in those with NCDs. Those with 
chronic illness tend to be hypervigilant regarding symptoms and sensations (McDermid, 
Rollman, & McCain, 1996). Chronic illnesses often lead to a variety of sensory experiences that 
may alert the individual to when something is wrong within the body. While a patient may know 
to watch for these symptoms, they can be anxious and become hypervigilant, feeling symptoms 
that are provoked by the anxiety and not related to the illness. Anxiety sensitivity (AS) refers to 
fears of anxiety-related sensations due to beliefs that the sensations are associated with negative 
physical, psychological, or social outcomes (Reiss, Peterson, Gursky, & McNally, 1986). Wong 
et al. (2014) found in chronic pain patients that pain hypervigilance mediates the relationship 
between AS and catastrophizing pain. For instance, a hypervigilant patient with lung disease may 
sense shortness of breath after a bout of movement more than a healthy patient would in the 
same situation. The patient with the illness may perceive this to be a sign that the condition of 
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their lungs is deteriorating and become anxious. They may catastrophize this feeling into 
believing their lung collapsed or they are experiencing some other serious medical problem. In 
this case, hypervigilance can be maintained the patient’s AS, which itself has been marked as a 
risk factor for anxiety disorders (Zvolenskya, Schmidt, Bernsteina, & Keough, 2006).  
As mentioned above, AS is a risk factor for the development of various anxiety disorders. 
AS is the fear of anxiety symptoms that comes from the belief that anxiety may result in physical 
harm (Reiss, 1991).  Furthermore, AS has been broken down into three factors, physical 
concerns, social concerns, and psychological or cognitive concerns (Zinbarg, Barlow & Brown, 
1997). Physical AS includes the belief that physical symptoms may be a sign of illness and the 
fear that results from that. Social AS is fear that others can observe the anxiety symptoms and it 
will result in embarrassment or ridicule. Lastly, psychological AS is fear that cognitive anxiety 
symptoms are proof of mental incapacitation (Stewart, Taylor, & Baker, 1997).  The study done 
by Zinbarg et al. (1997) showed that increased physical AS was associated with greater rates of 
panic disorder, while higher social AS was associated with social phobia. Increased cognitive AS 
on the other hand, was not related to a single anxiety disorder, but differentiated diagnosis of an 
anxiety disorder from that of no anxiety disorder, with the exception of simple phobia (Zinbarg 
et al., 1997). Reiss and McNally (1985) propose that AS is an individualized personality factor 
relevant in the development of anxiety disorders. AS has been found to be an identifier for 
substance abuse (Stewart, Samoluk, & MacDonald, 1999), PTSD (Marshall, Miles, & Stewart, 
2010), Panic (Maller & Reiss, 1992), and Agoraphobia (Wardle, Ahmad, & Hayward, 1990). 
These four associations show importance in their link to chronic illness.  
Often times those who have been diagnosed with a chronic illness are prescribed several 
types of medications and in some cases, may try to self-medicate. Stewart et al. (1999), 
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investigate the links between various substances being used and abused and their link with AS. 
Their review suggested a relationship between AS and misuse of substances such as 
benzodiazepines and analgesics that are commonly prescribed to those with chronic illness. 
Because of a link between high AS and substance use and the possible link between AS and 
chronic illness, AS may be a marker predicting substance misuse and abuse among a chronically 
ill population.  
PTSD may also be linked to chronic illness. A patient with chronic illness may 
experience a spell related to their disease that is later traumatizing to them. This traumatization 
may cause them to avoid certain situations or places that produce symptoms similar to those that 
occurred at the time of their spell. That scenario shows the relationship between high AS and 
PTSD. Furthermore, research has shown that AS can predict future PTSD symptoms. Therefore, 
patients with high AS are less likely to see a decrease in their PTSD symptoms over time than 
their counterparts with low AS (Marshall et al., 2010). If research proves a link between AS and 
chronic illness, it could be seen that the chronically ill population would maintain higher rates of 
PTSD. 
Another demonstrated association with high AS is panic disorder. AS was proven to 
predict the number, frequency, and intensity of future panic attacks in a study done by Maller 
and Reiss (1992). It is proposed that the relationship between AS and panic is a result of a 
misinterpretation of symptoms (Cox, Borger, & Enns, 1999). So, a panic attack arises when an 
individual interprets what they are feeling as much more perilous than it actually is. This concept 
relates back to the topic of hypervigilance mentioned above. In the case of a chronically ill 
person, they may experience a rapid heart rate as a result of a stimulus and believe themselves to 
be having a heart attack leading themselves to panic. Hypervigilance led this person to have 
ANXIETY SENSITIVITY AND CHRONIC ILLNESS                                                               9 
 
 
   
 
increased awareness of their symptom, and AS led them to become anxious about the possibility 
of what an increased heart rate could mean. The increased anxiety led the patient to panic over an 
otherwise normal stimulus response. Because AS has been found to predict panic (Maller & 
Reiss, 1992), it serves a salient role in determining the risk of panic disorder in those who are 
chronically ill. 
Similar to panic, agoraphobia has also been found to have a link with AS (Wardle et al., 
1990).  Agoraphobia is the fear of places and situations that may lead to a feeling of being 
trapped, embarrassment, or otherwise related to increased anxiety. Wardle et al. (1990), found 
that agoraphobia is highly linked with AS markers regarding bodily symptoms. Therefore, an 
individual with agoraphobia would avoid a place if it had the possibility of causing a symptom to 
arise. In regard to the example given above, a person with chronic illness and high AS may know 
that their heart rate increases around groups of people, so they will avoid a sporting event, for 
instance, because they feel an increased heart rate will lead to heart attack. Knowing if AS serves 
as a link between agoraphobia and chronic illness, can lead to the understanding of why chronic 
illness causes a stark decrease in quality of life by determining if enjoyable experiences are being 
avoided for fear of anxiety sensations. 
The studies that have been done regarding relationships between anxiety disorders and 
high AS have a significant role in the research of AS in chronically ill populations. If a 
relationship between chronic illness and AS holds true, the links made above can identify 
possible comorbidities increasing impairment and decreasing quality of life. By understanding 
these relationships, better treatment and care may be provided. In addition, recognition of 
common comorbid disease could decrease medical spending. 
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Very few studies have examined the relation between AS and chronic illnesses. Norman 
and Lang (2005) noted that AS could be a characteristic that was present before an illness was 
diagnosed, but also that high AS may have developed as a result of the diagnosis. They utilized a 
sample of 389 participants gathered from VA and university primary care clinic waiting rooms. 
They had a fairly even split between men and women, about 54% of their sample was Caucasian, 
and 55% had been diagnosed with at least one chronic illness.  In their study they noted 
limitations that may have played a role in their study that we plan to improve upon. Norman and 
Lang utilized the original ASI measure for its brevity. They suggested that a more 
comprehensive measure be used, therefore, we used the ASI-3.  
In the previous study, AS was found to have a role in the functioning of patients with 
hypertension, heart disease and high cholesterol. The current study expected comparable results 
to the previous research that showed AS is higher in patients diagnosed with one or more chronic 
illnesses. Because, little research has been done on this topic, this study will serve to reinforce 
the idea that AS plays a role in the diminished functioning of chronically ill patients. The 
importance of replication is strengthened by the common comorbidities seen between chronic 
illness and anxiety disorders (Roy-Byrne et al., 2008).  This study aims to determine if the 
linking factor is, in fact, AS by replicating the results of Norman and Lang (2005), with the 
exception of functioning and neuroticism. This study evaluated functioning based on the World 
Health Organization’s Quality of Life measure (WHOQOL), and neuroticism were replaced by 
negative affect, which was measured with the Brief Symptom Inventory 18 as general distress. 
Based on the results of Norman and Lang (2005), we hypothesized that we would see an 
association between higher AS and the chronic diseases studied in our research. In addition, we 
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further hypothesized that in the population with chronic illness physical AS would be higher and 
quality of life will be decreased.  
 
Methods 
 The data for this study were previously collected for another study (see Shanely, Knab, 
Nieman, Jin, McAnulty, & Landram, 2010 for clinical trial details). The data represent a large 
sample of 1002 residents from a community in western North Carolina. Of the 1002 participants 
recruited by mass advertising, 941 completed all study requirements, including cognitive testing 
at base line and post treatment. Additionally, 42 participants were excluded from the calculations 
for high cholesterol due to insufficient data. 95% of participants were white/Caucasian, 1.8% 
were African American, and the remaining 3.2% were of other racial and ethnic background. 
Approximately 60% of the participants sampled were women. The age range of participants was 
18 to 85 with a mean of 45.96 (SD = 16.27).  During recruitment, ages were stratified to ensure 
that various age ranges had adequate representation. Forty percent of subjects recruited were 
between the ages 18-40, 40% were middle aged (41-65), and the remaining 20% were 66-85 and 
considered older aged adults. In addition to being stratified by age, participants were also 
stratified by body mass index (BMI). Thirty-three percent were considered normal BMI (18.5-
24.9), 33% were considered overweight (25-29.9), and the remaining 33% were obese with BMI 
over 30. Almost 98% of the participants recruited had completed a high school education and 
56% had earned a college degree.  
 Subjects completed a Brief Symptom Inventory, the ASI-3, WHOQOL, and a health 
questionnaire. The ASI-3 is an 18 item self-report measure that was designed to measure fear of 
physiological arousal-related sensations, AS. The ASI-3 improved upon the ASI by focusing on 
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three subscales each with six items: physical (e.g, “It scares me when my heart beats rapidly”), 
cognitive (e.g. “It scares me when I am unable to keep my mind on a task”), and social concerns 
(e.g. “It is important for me to not appear nervous”). Each question is answered on a 0 - 4 point 
Likert scale (0 = very little, and 4 = very much) (Taylor et al., 2007). The Brief Symptom 
Inventory included questions regarding how the individual felt in that moment. The Brief 
Symptom Inventory general distress measure is also being used to predict negative affect. 
Research shows that the three subscales of the BSI-18 are positively correlated with negative 
affect (Serafini, Malin-Mayor, Nich, Hunkele & Carroll, 2016). Quality of Life was measured 
using the WHOQOL. The WHOQOL has 115 questions and gathers information based on each 
individuals’ perception of their place in life in the context of their values and culture relating to 
their goals and expectations. Lastly, the health questionnaire included demographic questions, 
medical history questions, a self-report on chronic disease, risk factors for chronic disease, and 
questions about lifestyle. Around 38% of participants reported a history including one or more 
chronic disease. 28% of participants reported having one chronic disease, 8.9% reported two, and 
0.8 reported three or more. Chronic diseases to be considered in this study and the respective 
percentage of persons afflicted include: heart disease (1.9%), hypertension (18.3%), high 
cholesterol (12.4%), and arthritis (15.5%). The breakdown of diseases and their respective AS 
and quality of life scores can be seen in Table 1. These four diseases were chosen based on their 
inclusion in the previously done study done by Norman and Lang (2005).  
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Table 1: Breakdown of Chronic Illnesses with AS and Quality of Life Scores 
 N Mean age 
Sex Subfactors of AS- mean Quality of Life-
mean 
Male Female Physical Cognitive Social 
Hypertension 191 57 84 107 5 3 6 71.84 
High cholesterol 129 53 35 93 4 3 5 72.02 
Heart Disease 20 69 14 6 5 3 5 70.11 
Arthritis 162 57 40 121 5 3 6 70.30 
Number of 
diseases 
0 609 40 250 359 3 2 6 73.79 
1 292 53 119 173 4 3 6 71.77 
>1 101 62 26 74 5 4 5 70.68 
 
Analysis Plan 
Hierarchical logistic regression analyses were performed to determine whether the three 
subfactors of AS predicted unique variance in each of the chronic illnesses over and above 
demographic variables and negative affect. Each chronic illness served as a dependent variable in 
one analysis. At Step 1, age, gender, and the BSI General Distress subscale were entered in to the 
regression model. Participants’ scores on the Physical, Cognitive, and Social Concerns subscales 
of the ASI-3 were entered at Step 2, consistent with methodology used by Norman and Lang 
(2005). Age was included because there tends to be a higher prevalence of chronic illness as age 
increases. Also, chronic illnesses affect each gender at different rates (e.g., more women are 
diagnosed with arthritis than men [Arthritis Foundation, 2017]). Watson and Pennebaker (1989) 
found that negative affect was significantly correlated with health complaints. Therefore, we 
included negative affect in the model. The selected variables were also chosen based on their 
inclusion in the previous study that is being replicated (Norman & Lang, 2005).  
Furthermore, a separate hierarchical regression analysis was conducted to determine if 
AS scores predicted number of chronic illnesses. In this analysis, number of chronic illnesses 
was the dependent variable, and the entry of indicator variables was the same as described above.  
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Lastly, a hierarchical multiple regression analysis was conducted to determine if AS 
subscale scores predicted quality of life over and above demographic variables and negative 
affect among individuals who met criteria for one or more chronic disease. Scores on the 
WHOQOL-BREF served as the independent variable, and the predictor variables were entered 
into the model as described above.  
Results 
 Correlational analysis was used to examine a general relationship between chronic illness 
and AS, as well as demographic variables and negative affect. Preliminary results indicated weak 
relationships between age and chronic illness. Other weak associations were seen between 
chronic illness and AS and negative affect. The correlational analysis also indicated relationships 
between number of diseases and AS, demographic variables, and negative affect. Quality of life 
was seen to have a relationship with the same variables (Table 2).  
Table 2: Correlation of Variables 
 
Age Gender BSI General Distress Physical AS Cognitive AS Social AS 
Hypertension .329 -.045 .041 .108 .030 -.012 
Heart Disease .199 -.089 .016 .057 .017 -.025 
High Cholesterol .164 .095 .042 .011 .081 -.020 
Arthritis .301 .131 .105 .101 .111 -.008 
Number of Diseases .464 .072 .102 .132 .119 -.026 
Quality of Life -.019 -.047 -.534 -.283 -.397 -.267 
 
The overall logistic regression analyses for hypertension, high cholesterol, arthritis, and 
heart disease were significant. In the final models, age was a significant predictor of each chronic 
illness, and gender significantly predicted all except heart disease (p = .059). However, the ASI-3 
Physical Concerns subscale was only associated with hypertension after controlling for 
demographic variables and negative affect (p < .01), and the Cognitive Concerns subscale was 
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only associated with high cholesterol (p = 0.02). The Social Concerns subscale did not predict 
any of the chronic illnesses, and none of the ASI-3 subscales predicted heart disease or arthritis. 
The results of the linear regression analyses can be seen in Table 3.  
Table 3: Chronic illness and the three subscales of AS with co-variates 
Chronic Disease/Variable 
Cox and 
Snell R2 
Chi square β Wald P 
Hypertension 
      Physical AS 
        Social AS 
        Cognitive AS 
        Age 
        Sex 
        BSI General Distress 
.122 8.409 0  
.72 
.008 
-.043 
.060 
-.453 
.012 
0  
6.355 
.087 
1.827 
84.087 
6.142 
.967 
 0 
.012 
.768 
.176 
.000 
.013 
.326 
High Cholesterol 
      Physical AS 
        Social AS 
        Cognitive AS 
        Age 
        Sex 
        BSI General Distress 
.041 5.431 0  
-.042 
-.012 
.074 
.031 
.523 
.007 
0  
1.581 
.152 
5.322 
21.784 
5.779 
.267 
 0 
.209 
.696 
.021 
.000 
.016 
.606 
Heart Disease 
      Physical AS 
        Social AS 
        Cognitive AS 
        Age 
        Sex 
        BSI General Distress 
.048 
 
1.413 0  
.072 
.007 
-.001 
.125 
-1.031 
.021 
0  
.799 
.007 
.000 
23.457 
3.552 
.379 
0  
.371 
.934 
.991 
.000 
.059 
.538 
Arthritis 
      Physical AS 
        Social AS 
        Cognitive AS 
        Age 
        Sex 
        BSI General Distress 
.118 3.853 0  
.036 
-.024 
.031 
.059 
.743 
.027 
0  
1.543 
.754 
.980 
68.988 
12.051 
4.860 
 
 0 
.214 
.385 
.322 
.000 
.001 
.027 
 
Our second aim was to determine if the AS predicted number of chronic illnesses 
endorsed. The overall regression model was significant, but, in the final model, only age and 
gender significantly predicted number of chronic diseases (Table 4).  
A hierarchical multiple regression analysis was conducted to determine if AS subscale 
scores predicted quality of life among individuals with chronic illnesses (n = 393). The overall 
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regression model was significant, and, in the final model, age, BSI-General Distress, and ASI-3 
Cognitive Concerns were all significant predictors of quality of life (Table 4).  
Table 4: Anxiety Sensitivity Predicts Number of Chronic Illness and Quality of Life 
  Adjusted R2 F β t P 
Number of Chronic 
Diseases 
      Physical AS  
        Social AS  
        Cognitive AS  
        Age  
        Sex  
        BSI General Distress  
 
.222 45.838  0 
 
.057 
-.026  
 .049 
.447 
.024 
.055 
-5.380 
 
1.443 
-.701 
 1.285 
15.084 
.830 
1.696 
.000 
 
.149 
.483 
 .199 
.000 
.407 
.090 
Quality of Life 
      Physical AS  
        Social AS  
        Cognitive AS  
        Age  
        Sex  
        BSI General Distress  
.320 30.301 0 
 
-.002 
-.050 
-.175 
.095 
.027 
-.433 
31.821 
 
-.032 
-.860 
-2.948 
2.170 
.635 
-9.179 
.000 
 
.974 
.003 
.391 
.031 
.526 
.000 
 
Discussion 
 The results from the current study suggest that certain chronic illnesses may be associated 
with the subfactors of AS. We found that physical AS was predictive of hypertension and 
cognitive AS was predictive of high cholesterol. However, neither of the other two illnesses that 
we studied had a significant relationship with any subfactor of AS. This could suggest that 
certain illnesses present with specific signs and symptoms that could increase AS, instead of the 
presence of illness in general impacting AS. Symptoms related to hypertension are commonly 
physical in nature and align closely with physical AS subscale questions. For example, "When I 
feel pain in my chest, I worry that I am going to have a heart attack," or "When I notice my heart 
skipping a beat, I worry that there is something seriously wrong with me." While hypertension is 
mainly asymptomatic, two possible symptoms are chest pain and irregular heartbeat, matching 
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the ASI-3 questions. While heart disease has similar symptoms, only a small percentage (<2%) 
of our sample had been diagnosed, which is not representative of the total heart disease 
population.  
While no relationship was found between physical AS and high cholesterol, we did find 
that cognitive AS was predictor. This could be explained by the relationship high cholesterol has 
with cognitive decline, dementia, and Alzheimer's Disease. Anstey, Lipnicki, and Low (2008) 
conducted a systematic review of prospective studies and found that high total cholesterol could 
be linked to declines in cognitive abilities, such as dementia and Alzheimer's. They found this to 
be especially true if high cholesterol was reported in middle-aged adults. High cholesterol's role 
in cognitive decline could explain why there is a significant relationship with cognitive AS.  
Arthritis was found to have no relationship with any subfactor of AS. As opposed to the 
other three chronic illnesses analyzed in this study, no symptom of arthritis is specifically out 
lined by the ASI-3 questions. This eliminates the possibility of increased AS due to specific 
symptoms. Norman and Lang (2005) explained that the lack of significant relationship could also 
be due to the symptomatic nature of the disease. Hypertension, heart disease, and high 
cholesterol are mainly asymptomatic, so when symptoms do arise they cause increased anxiety 
and AS. Arthritis patients often live with daily symptoms. Having constant exposure to 
symptoms may decrease the amount of anxiety and AS attributed to them over time. These are 
two possible explanations as to why AS cannot predict arthritis, but more research is needed to 
further investigate possible relationships.  
The relationship between the presence of multiple chronic illnesses and AS was also 
investigated. Both physical and cognitive AS were related to the individual having more than one 
chronic illness. This could be the result of a common co-morbidity between hypertension and 
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high cholesterol, where each illness raises their respective subfactor of AS as discussed above. 
These two illnesses have many of the same risk factors (i.e. sedentary lifestyle, unhealthy diet, 
smoking) resulting in over half of all individuals with hypertension also being diagnosed with 
high cholesterol (American Heart Association, 2017). This result also suggests that AS increases 
as the disease burden increases. In addition, we found that in our chronically ill sample quality of 
life decreased as all subfactors of AS increased. This implies that as disease burden grows so 
does functional impairment. A preliminary assumption can be made that the addition of AS to 
the normal physical burden of chronic illness increases both mental and social impairment as 
well. More research is needed to further investigate and better understand that relationship. 
The relationships that have been identified between AS and chronic illness indicate a 
need for increased education on the topic. The general public is widely unaware, first, of what 
AS is and, second, that it has an interaction with a physical chronic illness. Bettering education 
can help individuals understand aspects of anxiety and the realistic risk of anxiety related 
sensations, while learning about their disease and its signs and symptoms. This education can 
help individuals to more easily manage and cope with their illnesses. Education on the topic 
could also facilitate better interventions. Knowing there is a relationship between AS and chronic 
illness can lead to an interdisciplinary treatment plan that lowers overall disease burden. An 
unhealthy lifestyle is one of the main risk factors for chronic illness as a whole. Therefore, 
recognizing the relationship between AS and chronic illness reinforces not only the physical but 
mental benefits of a healthy lifestyle.  
This study was intended to be a replication of the 2005 study performed by Norman and 
Lang. While some of our findings corresponded, the majority differed from their results. There 
are many things that could have attributed to the difference. For one, we utilized different 
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measures. Where they used the original ASI we chose the ASI-3, which is more comprehensive 
in measuring the three subscales of AS. We also exchanged their neuroticism measure for 
general distress as measured by the BSI and substituted the WHO's quality of life measure for 
functioning. While not likely to cause a dramatic difference in results, these substitutions may 
account for the discrepancies in results between the two studies. Our sample population also 
differed from that of the previous study, which could have led to differing results. The sample for 
this study had very little diversity and was mainly white. Females were also the majority in this 
sample, so gender differences could be an attributing factor. In addition to the differences in 
demographics, the samples were collected differently. The previous study pulled individuals 
from clinics in a larger city while this study took a community sample from a small town.  
The limitations to this study somewhat align with the reasons that were given for 
discrepancy in results between the two studies. A direct measure of neuroticism should be used. 
This study did not have access to a direct measure so general distress measured with the BSI 
took its place after research suggested it could be an adequate alternative. The sample for this 
study was also limited. In further research, a more stratified sample could be of benefit, as 
different illnesses present in other ethnic and socioeconomic groups. In addition this study did 
not analyze gender differences, however, gender could play a key factor and its role should be 
further investigated. Another limitation to our study was small samples. For example, our heart 
disease sample was too small to confidently extrapolate the data to the entire population with 
heart disease. Larger sample sizes should be considered if further research should be done. The 
small R2 values discovered in our analysis suggest that other factors not examined in this may be 
contributing to the predictive relationships. Any later research, should further investigate 
additional influences. Our cross-sectional design was another limitation to this study. We were 
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not able to determine if chronic illness preceded the AS or vice versa because of the design. If 
possible, further research on this topic should attempt a longitudinal design. Any other research 
should also further investigate symptom specific anxiety. As discussed above, certain illnesses 
have physical symptoms that make them more likely to answer physical AS subscale questions. 
While this study shows that there is a relationship between elevated AS and decreased 
functioning in chronically ill populations, additional research is needed to understand the extent 
of these relationships and the implications they could have for those with chronic illness.  
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